NYSE · Financial Statements

Encompass Health Corporation (EHC) Financial Statements

$124.09 NYSE: EHC Market Cap $12.24B

Encompass Health Corporation most recently reported annual revenue of $5.9B, net profit of $566.0M. Revenue grew at an average annual rate of 10.7% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Encompass Health Corporation: Revenue rose from $3.6B in 2016 to $5.9B in 2025, a change of +62.9% over 9 years; net profit was positive in all 10 reported years; operating margin was broadly flat at about 17.7%; the most recent year shows net profit of $566.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$3.6B$3.9B$4.3B$4.6B$3.6B$4.0B$4.3B$4.8B$5.4B$5.9B
Operating Expenses$3.0B$3.3B$3.6B$3.9B$3.6B$3.4B$3.7B$3.1B$4.5B$4.9B
Operating Profit$649.0M$649.0M$682.0M$693.0M$0$659.0M$630.0M$1.7B$865.0M$1.1B
Operating Margin17.8%16.6%15.9%15.0%0.0%16.4%14.5%35.9%16.1%17.7%
Other Income$-167.0M$-153.0M$-188.0M$-130.0M$353.0M$-154.0M$-179.0M$-1.1B$-115.0M$-100.0M
Interest$172.0M$154.0M$147.0M$160.0M$184.0M$164.0M$176.0M$144.0M$137.0M$123.0M
Depreciation$173.0M$184.0M$200.0M$219.0M$203.0M$220.0M$244.0M$274.0M$300.0M$328.0M
Profit Before Tax$482.0M$496.0M$493.0M$562.0M$353.0M$505.0M$451.0M$607.0M$750.0M$953.0M
Tax$34.0M$29.4M$24.1M$20.6M$21.2M$20.2M$22.2M$21.8M$20.0M$20.2M
Net Profit$248.0M$271.0M$292.0M$359.0M$284.0M$412.0M$271.0M$352.0M$456.0M$566.0M
EPS$2.59$2.69$2.93$3.61$2.85$4.11$2.70$3.47$4.46$5.54
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$1.2B$1.2B$1.3B$1.3B$1.4B$1.4B$1.5B$1.5B$1.5B$1.5B$1.6B$1.6B
Operating Expenses$777.0M$802.0M$1.1B$1.1B$1.1B$1.2B$1.2B$1.2B$1.2B$1.3B$1.3B$1.3B
Operating Profit$430.0M$445.0M$208.0M$216.0M$209.0M$232.0M$267.0M$259.0M$244.0M$283.0M$302.0M$288.0M
Operating Margin35.7%35.7%15.8%16.6%15.5%16.5%18.4%17.8%16.5%18.4%19.0%18.1%
Interest$36.0M$35.0M$35.0M$34.0M$35.0M$33.0M$32.0M$30.0M$31.0M$30.0M$32.0M$33.0M
Profit Before Tax$145.0M$165.0M$178.0M$186.0M$184.0M$201.0M$239.0M$237.0M$220.0M$258.0M$289.0M$262.0M
Tax$20.9M$22.6M$21.5M$20.6M$19.6M$18.7M$17.4M$21.5M$20.4M$21.5M$19.5M$20.5M
Net Profit$85.0M$88.0M$113.0M$114.0M$108.0M$121.0M$152.0M$142.0M$127.0M$146.0M$195.0M$154.0M
EPS$0.84$0.86$1.10$1.12$1.06$1.18$1.48$1.39$1.24$1.43$1.93$1.54

Over the 10 years reported for Encompass Health Corporation, borrowings decreased from $3.0B in 2016 to $2.7B in 2025, cash stood at $103.0M in the latest year, shareholders' equity was $1.0M, current assets covered current liabilities 1.08 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$4.7B$4.9B$5.2B$6.1B$6.4B$6.9B$5.6B$6.1B$6.5B$7.1B
Current Assets$655.0M$702.0M$662.0M$756.0M$949.0M$921.0M$717.0M$842.0M$887.0M$906.0M
Cash$41.0M$54.0M$69.0M$95.0M$224.0M$49.0M$22.0M$104.0M$85.0M$103.0M
Inventory$61.0M$62.0M$59.0M$0$0$0$0$0$0$0
Receivables$444.0M$472.0M$468.0M$499.0M$563.0M$502.0M$537.0M$612.0M$599.0M$619.0M
Fixed Assets$1.4B$1.5B$1.6B$2.2B$2.5B$2.8B$3.2B$3.5B$3.8B$4.3B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$47.0M$56.0M$74.0M$7.0M$6.0M$223.0M$152.0M$147.0M$123.0M$171.0M
Other Assets$1.9B$2.0B$2.1B$2.3B$2.3B$1.2B$1.3B$1.3B$1.3B$1.3B
Total Liabilities$3.6B$3.2B$3.4B$4.1B$4.4B$4.5B$3.8B$3.8B$3.7B$3.8B
Current Liabilities$476.0M$518.0M$673.0M$721.0M$717.0M$749.0M$576.0M$656.0M$841.0M$836.0M
Borrowings$3.0B$2.6B$2.5B$3.3B$3.5B$3.5B$3.0B$2.9B$2.7B$2.7B
Other Liabilities$599.0M$671.0M$842.0M$801.0M$901.0M$984.0M$782.0M$872.0M$972.0M$1.1B
Equity$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M
Reserves$736.0M$1.2B$1.3B$1.4B$1.6B$1.9B$1.3B$1.6B$2.1B$2.4B

For Encompass Health Corporation, operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $439.0M; free cash flow was positive in 10 of 10 years; financing activities used $333.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$606.0M$657.0M$762.0M$635.0M$705.0M$716.0M$706.0M$851.0M$1.0B$1.2B
Investing Cash Flow$-448.0M$-529.0M$-695.0M$-1.1B$-816.0M$-1.2B$-1.2B$-1.2B$-1.3B$-1.5B
Financing Cash Flow$-133.0M$-46.0M$-182.0M$-319.0M$-250.0M$-69.0M$452.0M$-53.0M$-26.0M$-333.0M
Net Cash Flow$-21.0M$14.0M$17.0M$26.0M$151.0M$-191.0M$-67.0M$51.0M$19.0M$-20.0M
Free Cash Flow$403.0M$412.0M$492.0M$231.0M$297.0M$165.0M$122.0M$268.0M$360.0M$439.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.97
EV / EBITDA9.75
FCF Yield3.48%
Quick Ratio1.19
Interest Coverage8.89
Return 1Y0.88%
Return 3Y91.32%
Return 5Y130.50%

Encompass Health Corporation (EHC) financials — frequently asked questions

What is Encompass Health Corporation's annual revenue?

Encompass Health Corporation (EHC) reported annual revenue of $5.9B in its most recent fiscal year.

What is Encompass Health Corporation's net profit?

Encompass Health Corporation (EHC) reported net profit of $566.0M in its most recent fiscal year.

What is EHC EV/EBITDA?

Encompass Health Corporation's enterprise value to EBITDA (EV/EBITDA) ratio is 9.75.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
EHC Overview EHC Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.